CELGENE MANAGEMENT SARL - CH 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 8.728.185 0 1
2020 0 6.715.625 0 1
2019 0 8.713.395 0 1
2018 0 14.105.750 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BAYER4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN HEMATOLOGY ASSOCIATION2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS2
JANSSEN PHARMACEUTICA NV2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
NOVARTIS PHARMA2
OSPEDALE PEDIATRICO BAMBINO GESU2
PFIZER LIMITED2
STICHTING VUMC2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
UNIVERSIDAD DE NAVARRA2
ABBVIE INC1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
BIOSCI CONSULTING BVBA1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
DRUGS FOR NEGLECTED DISEASES INITIATIVE FONDATION1
ELI LILLY AND COMPANY LIMITED1
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS1
FORUM DES PATIENTS EUROPEENS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
FUNDACION HOSPITAL LA FE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
GENOME RESEARCH1
GMV SOLUCIONES GLOBALES INTERNET SAU1
GPOH GEMEINNUTZIGE1
GROUPE FRANCOPHONE DES MYELODYSPLASIES1
HOSPITAL CLINIC DE BARCELONA1
IFAKARA HEALTH INSTITUTE TRUST1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT NATIONAL DU CANCER GIP1
INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT1
ISTITUTO NAZIONALE DI FISICA NUCLEARE1
LEUKANET EV1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LYSARC1
MASARYKOVA UNIVERZITA1
MEDISAPIENS OY1
MEDIZINISCHE UNIVERSITAET WIEN1
MENARINI RICERCHE1
MILTENYI BIOTEC BV & CO KG1
MLL MUNCHNER LEUKAMIELABOR1
MUSEUM NATIONAL D'HISTOIRE NATURELLE1
ODYSSEUS DATA SERVICES SRO1
SANOFIAVENTIS1
STIFTELSEN WHO COLLABORATING CENTRE FOR INTERNATIONAL DRUG MONITORING1
STIFTUNG ELN FOUNDATION1
SWISS TROPICAL INSTITUTE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TARTU ULIKOOL1
TCURX1
TECHNISCHE UNIVERSITAET MUENCHEN1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE HYVE BV1
THE LYMPHOMA STUDY ASSOCIATION1
UCB BIOPHARMA1
UNIVERSIDADE DE AVEIRO1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAET ULM1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITATSKLINIKUM BONN1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF BUEA1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF NEWCASTLE UPON TYNE1
VIB VZW1

Constancy:

Total number of partners: 96
Partner loyalty:
Frequent Partner: (> 2 projects): 4
Rare Partner: 92
Frequent / Rare Partner Ratio: 0.04

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2019-09-01Collaboration for innovation: Establishment of a pan-nematode drug development platform HELPparticipant8.713.3958
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022